A notable advancement in glucose care is emerging with the release of tirzepatide at a dosage of 45mg. This innovative formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://mohamaduzrj491338.ampedpages.com/significant-introduction-tirzepatide-dose-for-glucose-control-67729889